X-BODY, INC.

COMBIND

Biomolecular screening sensors; optical scanners and high throughput screening instruments used to measure the output from biomolecular screening sensors; laboratory wellplates, namely, laboratory ware embedded with optical resonance structures used for biomolecular screening; holographic diffraction gratings used for biomolecular screening;

SRU BIND

Biomolecular screening sensors; optical scanners and high throughput screening instruments used to measure the output from biomolecular screening sensors; laboratory well plates, namely, laboratory ware embedded with optical resonance structures used for biomolecular screening; holographic diffraction gratings used for biomolecular screening; BIND;

SRU BIOSYSTEMS

Biomolecular screening sensors; optical scanners and high throughput screening instruments used to measure the output from biomolecular screening sensors; laboratory wellplates, namely, laboratory ware embedded with optical resonance structures used for biomolecular screening; holographic diffraction gratings used for biomolecular screening;BIOSYSTEMS;

X-BODY

Pharmaceuticals, namely, antibody and protein therapeutics for the treatment of neoplastic disease, cancer, inflammatory disorders, infectious disease, metabolic disease, and genetic disorders;

X-BODY

Scientific research and development involving discovery of antibodies against therapeutic targets;